Cargando…

The role of partners in promoting self-care for misoprostol and subcutaneous DMPA in Pakistan

BACKGROUND: Pakistan is among a number of countries facing protracted challenges in addressing maternal mortality with a concomitant weak healthcare system complexed with inequities. Sexual and reproductive health and rights (SRHR) self-care interventions offer the best solution for improving access...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uzma, Qudsia, Hamid, Nausheen, Chaudhri, Rizwana, Mehmood, Nadeem, Aabroo, Atiya, Thom, Ellen, Gholbzouri, Karima, Mahaini, Ramez, Hemachandra, Nilmini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058573/ https://www.ncbi.nlm.nih.gov/pubmed/33882966 http://dx.doi.org/10.1186/s12961-021-00714-0

Ejemplares similares

An assessment of facility readiness for comprehensive abortion care in 12 districts of Pakistan using the WHO Service Availability and Readiness Assessment tool
por: Mahipala, Palitha Gunarathna, et al.
Publicado: (2023)

Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC)
por: Stout, Anna, et al.
Publicado: (2018)

Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal()()
por: Mvundura, Mercy, et al.
Publicado: (2019)

Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results
por: Okegbe, Tishina, et al.
Publicado: (2019)

Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda
por: Anglewicz, Philip, et al.
Publicado: (2019)

Analysis of misoprostol and chlorhexidine policy gains in Pakistan: the advocacy experience of Mercy Corps Pakistan
por: Sarwar, Zahida, et al.
Publicado: (2015)

Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study()()()
por: Cover, Jane, et al.
Publicado: (2017)

Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
por: Anglewicz, Philip, et al.
Publicado: (2021)

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
por: Porter Erlank, Chelsey, et al.
Publicado: (2023)

Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
por: Zuberi, Nadeem F, et al.
Publicado: (2008)

Assessing risk criteria and HIV prevalence in antenatal clinic clients from 2 urban tertiary hospitals in Pakistan
por: Shabbir, Naveeda, et al.
Publicado: (2010)

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries
por: Stout, Anna, et al.
Publicado: (2018)

DMPA-SC stock: Cross-site trends by facility type
por: Magalona, Sophia, et al.
Publicado: (2022)

Scale-up of the DMPA-SC in Nigeria: Why policy matters
por: Akinyemi, Oluwaseun, et al.
Publicado: (2022)

Induction of Labor in Primigravid Term Pregnancy with Misoprostol or Dinoprostone: A Comparative Study
por: Arif, Rizwana, et al.
Publicado: (2019)

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda
por: Odwe, George, et al.
Publicado: (2018)

Benefit-risk analysis of maintaining essential Reproductive, Maternal, Newborn, and Child Health (RMNCH) services against risk of COVID-19 infection
por: Weissman, Eva, et al.
Publicado: (2022)

Effect of DMPA and Molecular Weight of Polyethylene Glycol on Water-Soluble Polyurethane
por: Wondu, Eyob, et al.
Publicado: (2019)

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi
por: Burke, Holly M., et al.
Publicado: (2019)

Advancing maternal and perinatal health in low- and middle-income countries: A multi-country review of policies and programmes
por: Syed, Uzma, et al.
Publicado: (2022)

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem
por: Ozgoli, Giti, et al.
Publicado: (2015)

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)()()
por: Katz, Micah, et al.
Publicado: (2020)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Foley catheter plus misoprostol versus misoprostol alone for labor induction
por: Elpo, Jhonathan Alcides, et al.
Publicado: (2023)

Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi
por: Ali, Gracious, et al.
Publicado: (2023)

Erratum for: Odwe et al., Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda
Publicado: (2019)

Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem
por: Veisi, Firoozeh, et al.
Publicado: (2013)

Sublingual misoprostol vs. oral misoprostol solution for induction of labor: A retrospective study
por: Amini, Mahdi, et al.
Publicado: (2022)

A comparative study on satisfaction from hormonal contraceptives: depot medroxyprogesterone acetate (DMPA), Cyclofem and LD
por: Fathizadeh, Nahid, et al.
Publicado: (2011)

Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model
por: Curry, Leslie, et al.
Publicado: (2013)

Exogenous oestrogen inhibits genital transmission of cell‐associated HIV‐1 in DMPA‐treated humanized mice
por: Quispe Calla, Nirk E, et al.
Publicado: (2018)

Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects()()
por: Liu, Jenny, et al.
Publicado: (2018)

Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers()()
por: Hernandez, Julie H., et al.
Publicado: (2018)

Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice
por: Wessels, Jocelyn M., et al.
Publicado: (2021)

Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: a cohort study
por: Bolla, Daniele, et al.
Publicado: (2018)

Prevalence of antimicrobial resistance and integrons in Escherichia coli from Punjab, Pakistan
por: Muhammad, Idrees, et al.
Publicado: (2011)

Research gaps and emerging priorities in sexual and reproductive health in Africa and the eastern Mediterranean regions
por: Ali, Moazzam, et al.
Publicado: (2018)

Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: Randomized controlled trial
por: Young, David C., et al.
Publicado: (2020)

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial
por: Mobeen, N, et al.
Publicado: (2011)

Seeking Synchrony Between Family Planning and Immunization: A Week-10 DMPA Start Option for Breastfeeding Mothers
por: Stanback, John
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s505r9srke25v95nv3aqvl9piu